Report Detail

Service & Software Global Custom Recombinant Antibody Production Service Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • RnM4550813
  • |
  • 22 August, 2023
  • |
  • Global
  • |
  • 110 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Service & Software

According to our (Global Info Research) latest study, the global Custom Recombinant Antibody Production Service market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Custom Recombinant Antibody Production Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Custom Recombinant Antibody Production Service market size and forecasts, in consumption value ($ Million), 2018-2029
Global Custom Recombinant Antibody Production Service market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Custom Recombinant Antibody Production Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Custom Recombinant Antibody Production Service market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Custom Recombinant Antibody Production Service
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Custom Recombinant Antibody Production Service market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include evitria, ProSci, GenScript, RayBiotech and Cygnus Technologies, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Custom Recombinant Antibody Production Service market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Monoclonal Antibody (mAb) Production
Polyclonal Antibody (pAb) Production
Market segment by Application
Pharmaceutics
Scientific Research
Others
Market segment by players, this report covers
evitria
ProSci
GenScript
RayBiotech
Cygnus Technologies
Cayman Chemical
Boster Bio
Bon Opus Biosciences
Biomatik
Abcam
Bio-Rad
Creative Biolabs
ProteoGenix
Sino Biological
Absolute Antibody
ProMab Biotechnologies
ACROBiosystems
Cusabio Technology
Covance
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Custom Recombinant Antibody Production Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Custom Recombinant Antibody Production Service, with revenue, gross margin and global market share of Custom Recombinant Antibody Production Service from 2018 to 2023.
Chapter 3, the Custom Recombinant Antibody Production Service competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Custom Recombinant Antibody Production Service market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Custom Recombinant Antibody Production Service.
Chapter 13, to describe Custom Recombinant Antibody Production Service research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Custom Recombinant Antibody Production Service
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Custom Recombinant Antibody Production Service by Type
    • 1.3.1 Overview: Global Custom Recombinant Antibody Production Service Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Custom Recombinant Antibody Production Service Consumption Value Market Share by Type in 2022
    • 1.3.3 Monoclonal Antibody (mAb) Production
    • 1.3.4 Polyclonal Antibody (pAb) Production
  • 1.4 Global Custom Recombinant Antibody Production Service Market by Application
    • 1.4.1 Overview: Global Custom Recombinant Antibody Production Service Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Pharmaceutics
    • 1.4.3 Scientific Research
    • 1.4.4 Others
  • 1.5 Global Custom Recombinant Antibody Production Service Market Size & Forecast
  • 1.6 Global Custom Recombinant Antibody Production Service Market Size and Forecast by Region
    • 1.6.1 Global Custom Recombinant Antibody Production Service Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Custom Recombinant Antibody Production Service Market Size by Region, (2018-2029)
    • 1.6.3 North America Custom Recombinant Antibody Production Service Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Custom Recombinant Antibody Production Service Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Custom Recombinant Antibody Production Service Market Size and Prospect (2018-2029)
    • 1.6.6 South America Custom Recombinant Antibody Production Service Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Custom Recombinant Antibody Production Service Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 evitria
    • 2.1.1 evitria Details
    • 2.1.2 evitria Major Business
    • 2.1.3 evitria Custom Recombinant Antibody Production Service Product and Solutions
    • 2.1.4 evitria Custom Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 evitria Recent Developments and Future Plans
  • 2.2 ProSci
    • 2.2.1 ProSci Details
    • 2.2.2 ProSci Major Business
    • 2.2.3 ProSci Custom Recombinant Antibody Production Service Product and Solutions
    • 2.2.4 ProSci Custom Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 ProSci Recent Developments and Future Plans
  • 2.3 GenScript
    • 2.3.1 GenScript Details
    • 2.3.2 GenScript Major Business
    • 2.3.3 GenScript Custom Recombinant Antibody Production Service Product and Solutions
    • 2.3.4 GenScript Custom Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 GenScript Recent Developments and Future Plans
  • 2.4 RayBiotech
    • 2.4.1 RayBiotech Details
    • 2.4.2 RayBiotech Major Business
    • 2.4.3 RayBiotech Custom Recombinant Antibody Production Service Product and Solutions
    • 2.4.4 RayBiotech Custom Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 RayBiotech Recent Developments and Future Plans
  • 2.5 Cygnus Technologies
    • 2.5.1 Cygnus Technologies Details
    • 2.5.2 Cygnus Technologies Major Business
    • 2.5.3 Cygnus Technologies Custom Recombinant Antibody Production Service Product and Solutions
    • 2.5.4 Cygnus Technologies Custom Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Cygnus Technologies Recent Developments and Future Plans
  • 2.6 Cayman Chemical
    • 2.6.1 Cayman Chemical Details
    • 2.6.2 Cayman Chemical Major Business
    • 2.6.3 Cayman Chemical Custom Recombinant Antibody Production Service Product and Solutions
    • 2.6.4 Cayman Chemical Custom Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Cayman Chemical Recent Developments and Future Plans
  • 2.7 Boster Bio
    • 2.7.1 Boster Bio Details
    • 2.7.2 Boster Bio Major Business
    • 2.7.3 Boster Bio Custom Recombinant Antibody Production Service Product and Solutions
    • 2.7.4 Boster Bio Custom Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Boster Bio Recent Developments and Future Plans
  • 2.8 Bon Opus Biosciences
    • 2.8.1 Bon Opus Biosciences Details
    • 2.8.2 Bon Opus Biosciences Major Business
    • 2.8.3 Bon Opus Biosciences Custom Recombinant Antibody Production Service Product and Solutions
    • 2.8.4 Bon Opus Biosciences Custom Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Bon Opus Biosciences Recent Developments and Future Plans
  • 2.9 Biomatik
    • 2.9.1 Biomatik Details
    • 2.9.2 Biomatik Major Business
    • 2.9.3 Biomatik Custom Recombinant Antibody Production Service Product and Solutions
    • 2.9.4 Biomatik Custom Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Biomatik Recent Developments and Future Plans
  • 2.10 Abcam
    • 2.10.1 Abcam Details
    • 2.10.2 Abcam Major Business
    • 2.10.3 Abcam Custom Recombinant Antibody Production Service Product and Solutions
    • 2.10.4 Abcam Custom Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Abcam Recent Developments and Future Plans
  • 2.11 Bio-Rad
    • 2.11.1 Bio-Rad Details
    • 2.11.2 Bio-Rad Major Business
    • 2.11.3 Bio-Rad Custom Recombinant Antibody Production Service Product and Solutions
    • 2.11.4 Bio-Rad Custom Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Bio-Rad Recent Developments and Future Plans
  • 2.12 Creative Biolabs
    • 2.12.1 Creative Biolabs Details
    • 2.12.2 Creative Biolabs Major Business
    • 2.12.3 Creative Biolabs Custom Recombinant Antibody Production Service Product and Solutions
    • 2.12.4 Creative Biolabs Custom Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Creative Biolabs Recent Developments and Future Plans
  • 2.13 ProteoGenix
    • 2.13.1 ProteoGenix Details
    • 2.13.2 ProteoGenix Major Business
    • 2.13.3 ProteoGenix Custom Recombinant Antibody Production Service Product and Solutions
    • 2.13.4 ProteoGenix Custom Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 ProteoGenix Recent Developments and Future Plans
  • 2.14 Sino Biological
    • 2.14.1 Sino Biological Details
    • 2.14.2 Sino Biological Major Business
    • 2.14.3 Sino Biological Custom Recombinant Antibody Production Service Product and Solutions
    • 2.14.4 Sino Biological Custom Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Sino Biological Recent Developments and Future Plans
  • 2.15 Absolute Antibody
    • 2.15.1 Absolute Antibody Details
    • 2.15.2 Absolute Antibody Major Business
    • 2.15.3 Absolute Antibody Custom Recombinant Antibody Production Service Product and Solutions
    • 2.15.4 Absolute Antibody Custom Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 Absolute Antibody Recent Developments and Future Plans
  • 2.16 ProMab Biotechnologies
    • 2.16.1 ProMab Biotechnologies Details
    • 2.16.2 ProMab Biotechnologies Major Business
    • 2.16.3 ProMab Biotechnologies Custom Recombinant Antibody Production Service Product and Solutions
    • 2.16.4 ProMab Biotechnologies Custom Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.16.5 ProMab Biotechnologies Recent Developments and Future Plans
  • 2.17 ACROBiosystems
    • 2.17.1 ACROBiosystems Details
    • 2.17.2 ACROBiosystems Major Business
    • 2.17.3 ACROBiosystems Custom Recombinant Antibody Production Service Product and Solutions
    • 2.17.4 ACROBiosystems Custom Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.17.5 ACROBiosystems Recent Developments and Future Plans
  • 2.18 Cusabio Technology
    • 2.18.1 Cusabio Technology Details
    • 2.18.2 Cusabio Technology Major Business
    • 2.18.3 Cusabio Technology Custom Recombinant Antibody Production Service Product and Solutions
    • 2.18.4 Cusabio Technology Custom Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.18.5 Cusabio Technology Recent Developments and Future Plans
  • 2.19 Covance
    • 2.19.1 Covance Details
    • 2.19.2 Covance Major Business
    • 2.19.3 Covance Custom Recombinant Antibody Production Service Product and Solutions
    • 2.19.4 Covance Custom Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.19.5 Covance Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Custom Recombinant Antibody Production Service Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Custom Recombinant Antibody Production Service by Company Revenue
    • 3.2.2 Top 3 Custom Recombinant Antibody Production Service Players Market Share in 2022
    • 3.2.3 Top 6 Custom Recombinant Antibody Production Service Players Market Share in 2022
  • 3.3 Custom Recombinant Antibody Production Service Market: Overall Company Footprint Analysis
    • 3.3.1 Custom Recombinant Antibody Production Service Market: Region Footprint
    • 3.3.2 Custom Recombinant Antibody Production Service Market: Company Product Type Footprint
    • 3.3.3 Custom Recombinant Antibody Production Service Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Custom Recombinant Antibody Production Service Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Custom Recombinant Antibody Production Service Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Custom Recombinant Antibody Production Service Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Custom Recombinant Antibody Production Service Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Custom Recombinant Antibody Production Service Consumption Value by Type (2018-2029)
  • 6.2 North America Custom Recombinant Antibody Production Service Consumption Value by Application (2018-2029)
  • 6.3 North America Custom Recombinant Antibody Production Service Market Size by Country
    • 6.3.1 North America Custom Recombinant Antibody Production Service Consumption Value by Country (2018-2029)
    • 6.3.2 United States Custom Recombinant Antibody Production Service Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Custom Recombinant Antibody Production Service Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Custom Recombinant Antibody Production Service Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Custom Recombinant Antibody Production Service Consumption Value by Type (2018-2029)
  • 7.2 Europe Custom Recombinant Antibody Production Service Consumption Value by Application (2018-2029)
  • 7.3 Europe Custom Recombinant Antibody Production Service Market Size by Country
    • 7.3.1 Europe Custom Recombinant Antibody Production Service Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Custom Recombinant Antibody Production Service Market Size and Forecast (2018-2029)
    • 7.3.3 France Custom Recombinant Antibody Production Service Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Custom Recombinant Antibody Production Service Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Custom Recombinant Antibody Production Service Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Custom Recombinant Antibody Production Service Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Custom Recombinant Antibody Production Service Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Custom Recombinant Antibody Production Service Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Custom Recombinant Antibody Production Service Market Size by Region
    • 8.3.1 Asia-Pacific Custom Recombinant Antibody Production Service Consumption Value by Region (2018-2029)
    • 8.3.2 China Custom Recombinant Antibody Production Service Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Custom Recombinant Antibody Production Service Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Custom Recombinant Antibody Production Service Market Size and Forecast (2018-2029)
    • 8.3.5 India Custom Recombinant Antibody Production Service Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Custom Recombinant Antibody Production Service Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Custom Recombinant Antibody Production Service Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Custom Recombinant Antibody Production Service Consumption Value by Type (2018-2029)
  • 9.2 South America Custom Recombinant Antibody Production Service Consumption Value by Application (2018-2029)
  • 9.3 South America Custom Recombinant Antibody Production Service Market Size by Country
    • 9.3.1 South America Custom Recombinant Antibody Production Service Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Custom Recombinant Antibody Production Service Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Custom Recombinant Antibody Production Service Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Custom Recombinant Antibody Production Service Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Custom Recombinant Antibody Production Service Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Custom Recombinant Antibody Production Service Market Size by Country
    • 10.3.1 Middle East & Africa Custom Recombinant Antibody Production Service Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Custom Recombinant Antibody Production Service Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Custom Recombinant Antibody Production Service Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Custom Recombinant Antibody Production Service Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Custom Recombinant Antibody Production Service Market Drivers
  • 11.2 Custom Recombinant Antibody Production Service Market Restraints
  • 11.3 Custom Recombinant Antibody Production Service Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 Custom Recombinant Antibody Production Service Industry Chain
  • 12.2 Custom Recombinant Antibody Production Service Upstream Analysis
  • 12.3 Custom Recombinant Antibody Production Service Midstream Analysis
  • 12.4 Custom Recombinant Antibody Production Service Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Custom Recombinant Antibody Production Service. Industry analysis & Market Report on Custom Recombinant Antibody Production Service is a syndicated market report, published as Global Custom Recombinant Antibody Production Service Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Custom Recombinant Antibody Production Service market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,742.24
    4,113.36
    5,484.48
    3,201.60
    4,802.40
    6,403.20
    541,557.60
    812,336.40
    1,083,115.20
    290,162.40
    435,243.60
    580,324.80
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report